{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:53:09Z","timestamp":1778777589806,"version":"3.51.4"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Corneal neovascularization is considered an important risk factor for allograft rejection after corneal transplantation (keratoplasty). Therefore, the aim of this study was to determine whether preoperative reduction of corneal neovascularization by fine-needle thermal cauterization combined with bevacizumab reduces the incidence of allograft rejection after subsequent high-risk keratoplasty.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>In this interventional uncontrolled clinical pilot study, 31 eyes of 31 patients with corneal neovascularization in at least one corneal quadrant were included. All eyes were treated by fine-needle thermal cauterization of corneal vessels and subconjunctival injection of bevacizumab. Both treatments were repeated in the cases of visible reperfusion of occluded vessels. Afterward, penetrating keratoplasty was performed. When corneal neovascularization was present on the day of keratoplasty, additional vessel cauterization and injection of bevacizumab was performed. Patients were then followed to determine the incidence of allograft rejection.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>In 18 eyes, vessel cauterization with bevacizumab injection was performed once before keratoplasty, whereas 13 eyes required retreatment before keratoplasty. No complications were observed. In 23 eyes, corneal neovascularization was present on the day of keratoplasty due to reperfusion of previously occluded vessels and simultaneous vessel cauterization with bevacizumab injection was performed. During follow-up (mean: 560 days; range: 59\u20131095 days), 4 graft rejection episodes in 4 eyes were observed. Estimated probabilities of corneal graft survival were 92.9% after 1 year (number at risk: 23), 78.4% after 2 years (number at risk: 9), and 78.4% after 3 years (number at risk: 3).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>Our initial results indicate that angioregressive treatment of pathological corneal vessels by fine-needle thermal cauterization combined with subconjunctival injection of bevacizumab before high-risk keratoplasty seems to result in graft survival rates comparable to survival rates seen in normal-risk keratoplasty. The findings of our pilot study warrant further controlled clinical trials with longer follow-up in a larger patient cohort.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/txd.0000000000000894","type":"journal-article","created":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T11:01:36Z","timestamp":1556362896000},"page":"e452","source":"Crossref","is-referenced-by-count":53,"title":["Risk of Corneal Graft Rejection After High-risk Keratoplasty Following Fine-needle Vessel Coagulation of Corneal Neovascularization Combined With Bevacizumab: A Pilot Study"],"prefix":"10.1097","volume":"5","author":[{"given":"Deniz","family":"Hos","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany."},{"name":"Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viet Nhat Hung","family":"Le","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Hellmich","sequence":"additional","affiliation":[{"name":"Institute of Medical Statistics and Computational Biology (IMSB), University of Cologne, Cologne, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Siebelmann","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigrid","family":"Roters","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bjoern O.","family":"Bachmann","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus","family":"Cursiefen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany."},{"name":"Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20231002","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nature05249","article-title":"Corneal avascularity is due to soluble VEGF receptor-1.","volume":"443","author":"Ambati","year":"2006","journal-title":"Nature"},{"key":"R2-20231002","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000099253","article-title":"Immune privilege and angiogenic privilege of the cornea.","volume":"92","author":"Cursiefen","year":"2007","journal-title":"Chem Immunol Allergy"},{"key":"R3-20231002","doi-asserted-by":"crossref","first-page":"11405","DOI":"10.1073\/pnas.0506112103","article-title":"Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision.","volume":"103","author":"Cursiefen","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R4-20231002","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.ajo.2010.01.005","article-title":"A method to confirm correct orientation of descemet membrane during descemet membrane endothelial keratoplasty.","volume":"149","author":"Bachmann","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"R6-20231002","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ajo.2007.03.028","article-title":"Long-term topical steroid treatment improves graft survival following normal-risk penetrating keratoplasty.","volume":"144","author":"Nguyen","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"R7-20231002","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1001\/archopht.1981.03930010599002","article-title":"Clinical types of corneal transplant rejection. Their manifestations, frequency, preoperative correlates, and treatment.","volume":"99","author":"Alldredge","year":"1981","journal-title":"Arch Ophthalmol"},{"key":"R8-20231002","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1001\/archopht.121.8.1087","article-title":"Risk factors for various causes of failure in initial corneal grafts.","volume":"121","author":"Price","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"R9-20231002","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1016\/j.transproceed.2007.08.020","article-title":"Epidemiology and risk factors for corneal graft rejection.","volume":"39","author":"Sellami","year":"2007","journal-title":"Transplant Proc"},{"key":"R10-20231002","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archopht.126.1.71","article-title":"Promotion of graft survival by vascular endothelial growth factor a neutralization after high-risk corneal transplantation.","volume":"126","author":"Bachmann","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"R11-20231002","doi-asserted-by":"crossref","first-page":"535","DOI":"10.4049\/jimmunol.0903180","article-title":"Cutting edge: lymphatic vessels, not blood vessels, primarily mediate immune rejections after transplantation.","volume":"184","author":"Dietrich","year":"2010","journal-title":"J Immunol"},{"key":"R12-20231002","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1038\/s41598-018-24037-3","article-title":"Fine needle-diathermy regresses pathological corneal (lymph)angiogenesis and promotes high-risk corneal transplant survival.","volume":"8","author":"Le","year":"2018","journal-title":"Sci Rep"},{"key":"R13-20231002","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.preteyeres.2013.01.001","article-title":"Novel anti(lymph)angiogenic treatment strategies for corneal and ocular surface diseases.","volume":"34","author":"Bock","year":"2013","journal-title":"Prog Retin Eye Res"},{"key":"R14-20231002","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.semcdb.2014.11.003","article-title":"Antilymphangiogenic therapy to promote transplant survival and to reduce cancer metastasis: what can we learn from the eye?","volume":"38","author":"Hos","year":"2015","journal-title":"Semin Cell Dev Biol"},{"key":"R15-20231002","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.ophtha.2014.03.038","article-title":"Aganirsen antisense oligonucleotide eye drops inhibit keratitis-induced corneal neovascularization and reduce need for transplantation: the I-CAN study.","volume":"121","author":"Cursiefen","year":"2014","journal-title":"Ophthalmology"},{"key":"R16-20231002","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ajo.2005.11.003","article-title":"Argon laser photodynamic therapy of human corneal neovascularization after intravenous administration of dihematoporphyrin ether.","volume":"141","author":"Sheppard","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R17-20231002","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s004170050257","article-title":"Treatment of HSV-1 stromal keratitis with topical cyclosporin A: a pilot study.","volume":"237","author":"Heiligenhaus","year":"1999","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R18-20231002","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1097\/ICO.0b013e318180e50f","article-title":"Bevacizumab (avastin) and argon laser to treat neovascularization in corneal transplant surgery.","volume":"27","author":"Gerten","year":"2008","journal-title":"Cornea"},{"key":"R19-20231002","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/ICO.0b013e31823f8f7a","article-title":"Angioregressive pretreatment of mature corneal blood vessels before keratoplasty: fine-needle vessel coagulation combined with anti-VEGFs.","volume":"31","author":"Koenig","year":"2012","journal-title":"Cornea"},{"key":"R20-20231002","first-page":"2148","article-title":"Fine needle diathermy occlusion of corneal vessels.","volume":"41","author":"Pillai","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R21-20231002","first-page":"291","article-title":"Q-switched Nd:YAG laser treatment for corneal neovascularization.","volume":"36","author":"Goto","year":"1992","journal-title":"Jpn J Ophthalmol"},{"key":"R22-20231002","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1136\/bjophthalmol-2013-303729","article-title":"Long-term outcomes of fine needle diathermy for established corneal neovascularisation.","volume":"98","author":"Trikha","year":"2014","journal-title":"Br J Ophthalmol"}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01845228-201905000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T07:17:41Z","timestamp":1696231061000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01845228-201905000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000000894","relation":{},"ISSN":["2373-8731"],"issn-type":[{"value":"2373-8731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5]]}}}